Latest News

August 16, 2019
The panel voted against recommending the prevention pill for use in cisgender women due to inadequate data on efficacy in this patient population.
 
August 16, 2019
A psoriasis researcher discusses a new class of psoriasis treatments.
August 16, 2019
This week, the top managed care stories included the Trump administration looking to bar legal immigrants from using public benefits; a study in The American Journal of Managed Care® finding that a law to limit surprise medical bills is working; data on Affordable Care Act enrollment showing the effect of subsidies.
August 16, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
August 16, 2019
The researchers called for more work to discover specific exposures in patients with leukemia that lead to infections after treatment ends.
August 16, 2019
The August issue of The American Journal of Managed Care® (AJMC®) featured research on surprise medical billing policies, social determinants of health, and the value of chimeric antigen receptor T-cell therapies, among other topics. Here are 5 findings from research published in the issue.
August 16, 2019
Parents treated for tobacco addiction within a pediatric office were associated with a significant decline in smoking rates as opposed to standard offices.
August 16, 2019
Generic drug makers are being accused of blocking a Congressional probe into their pricing practices; Illinois has become the first state to require insurance companies to pay for EpiPens for kids in cases of severe allergic reactions; Tufts Health Plan and Harvard Pilgrim Health will merge to create a new company covering 2.4 million people across New England.
August 15, 2019
FDA's approval of entrectinib for neurotrophic tyrosine receptor kinase (NTRK) fusion-positive tumors represents a new paradigm in cancer treatment; It treats a cancer based on a common biomarker seen across different tumors rather than based on the location in the body where the cancer originated. The FDA also gave approval to entrectinib for the treatment of adults with metastatic non–small cell lung cancer whose tumors are ROS1 positive.
August 15, 2019
Under a proposed rule released today, the agency would require new health warnings on cigarette packages and advertisements, which would feature pictures and images depicting some of the lesser-known health risks, including bladder cancer and heart disease.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.